Three groups at higher risk for leukemic induction treatment failure.

The article reports that researchers in France identified three groups at risk for leukemic induction failure in acute lymphoblastic leukemia (ALL) children patients. These include children with B-cell progenitor ALL considered as low-risk, children with T-cell ALL with mediastinal mass at moderate-risk, and children with a combination of both as high-risk groups. It shows a 30% versus 85% overall survival among 1,333 children enrolled in the French Acute Lymphoblastic Leukemia 93 (FRALLE 93) study.